日媒:丰田计划未来三个月生产230万辆汽车 按年升8%
《日本经济新闻》报道,日本丰田汽车将在本月起3个月内全球生产230万辆,较去年同期高8%,创历史新高。其中海外生产150万辆,按年升11%,日本本土则生产约80万辆,按年升3%。
报道指,中国及美国汽车需求推动丰田汽车产量复苏。中美市场共占丰田汽车去年四成销售。
调查公司MarkLines数据显示,中国9月新车销售按年升13%至256万辆,美国同期销售按年升6%至135万辆,後者为新冠疫情下首度录得增长。
报道亦指,丰田汽车9月全球产量已创出历史新高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.